QIAGEN Announces Supply Agreement to Provide Preanalytical Solutions to Osmetech Molecular Diagnostics

22-Nov-2005

QIAGEN GmbH, a wholly-owned subsidiary of QIAGEN N.V. and Osmetech molecular diagnostics., a division of Osmetech plc announced that they have entered into a distribution agreement. Pursuant to this agreement, Osmetech will incorporate certain preanalytical consumables and technologies from QIAGEN into Osmetech microarray-based solutions for use in diagnostic and research applications. QIAGEN's proprietary preanalytical technologies provide unmatched reproducibility and efficiency in molecular diagnostics applications.

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy